Home Agios

Agios

acquired
IPO
Biological New Drug Research and Development, Manufacturer
Basic
Enterprise Profile

Basic Information

Agios Pharmaceuticals is a biopharmaceutical company developing therapeutic drugs in the field of cancer metabolism. It also develops drugs focused on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutic drugs are used in the fields of autoimmune, inflammatory, and neurological diseases.
Agios Pharmaceuticals, Inc.
Cambridge,Massachusetts,United States of America
101~500 people
January 01, 2008
info@agios.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Tumor Immune System Diseases # Nervous System Diseases Therapeutic Products Leukemia
Application Scenarios
Biologics Innovative Drugs